Trends in serotype distribution and antimicrobial susceptibility in salmonella enterica isolates from humans in Belgium, 2009 to 2013

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 1, 2015, Pages 544-552

  Ceyssens, Pieter Jan ^a   Mattheus, Wesley ^a   Vanhoof, Raymond ^a   Bertrand, Sophie ^a  

^a SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOPENICILLIN; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; ASPARAGINE; CARBAPENEM DERIVATIVE; CEFOTAXIME; CEFOXITIN; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; GENTAMICIN; MEROPENEM; NALIDIXIC ACID; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; SERINE; STREPTOMYCIN; SULFONAMIDE; TETRACYCLINE; TRIMETHOPRIM; BACTERIAL PROTEIN; BETA LACTAMASE; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV;

ALLELE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BELGIUM; BETA LACTAMASE CTX M 14 GENE; BETA LACTAMASE CTX M 15 GENE; BETA LACTAMASE SHV 12 GENE; BETA LACTAMASE TEM 52 GENE; CLONAL SPECIES; CONTROLLED STUDY; GENETIC ASSOCIATION; NONHUMAN; PLASMID; SALMONELLA ENTERICA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR INFANTIS; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR KENTUCKY; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM; SEROTYPE; SEROTYPING; TREND STUDY; CLASSIFICATION; DRUG EFFECTS; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; SALMONELLA INFECTIONS;

BACTERIAL PROTEINS; BELGIUM; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CEFOTAXIME; CIPROFLOXACIN; DNA GYRASE; DNA TOPOISOMERASE IV; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; SALMONELLA ENTERICA; SALMONELLA INFECTIONS; SEROGROUP;

EID: 84920111510     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.04203-14     Document Type: Article

References (59)

1. European Food Safety Authority, European Centre for Disease Prevention and Control. 2013. The European Union summary report on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2011. EFSA J 11:3129. http://dx.doi.org/10.2903/j.efsa.2013.3129.
2. Vugia DJ, Samuel M, Farley MM, Marcus R, Shiferaw B, Shallow S, Smith K, Angulo FJ, Emerging Infections Program FoodNet Working Group. 2004. Invasive Salmonella infections in the United States, FoodNet, 1996 -1999: incidence, serotype distribution, and outcome. Clin Infect Dis 38 (Suppl 3) : S149 -S156. http://dx.doi.org/10.1086 /381581.
3. Guibourdenche M, Roggentin P, Mikoleit M, Fields PI, Bockemühl J, Grimont PA, Weill FX. 2010. Supplement 2003-2007 (no. 47) to the White-Kauffmann-Le Minor scheme. Res Microbiol 161:26-29. http://dx .doi.org/10.1016/j.resmic.2009.10.002.
4. Lauderdale TL, Aarestrup FM, Chen PC, Lai JF, Wang HY, Shiau YR, Huang IW, Hung CL, TSAR hospitals. 2006. Multidrug resistance among different serotypes of clinical Salmonella isolates in Taiwan. Diagn Microbiol Infect Dis 55: 149 -155. http://dx.doi.org/10 .1016/j.diagmicrobio.2006.01.002.
5. Parry CM, Threlfall EJ. 2008. Antimicrobial resistance in typhoidal and nontyphoidal salmonellae. Curr Opin Infect Dis 21:531-538. http://dx .doi.org/10.1097/QCO.0b013e32830f453a.
6. Jones TF, Ingram LA, Cieslak PR, Vugia DJ, Tobin-D'Angelo M, Hurd S, Medus C, Cronquist A, Angulo FJ. 2008. Salmonellosis outcomes differ substantially by serotype. J Infect Dis 198:109-114. http://dx.doi.org/10.1086 /588823.
7. Buckle GC, Walker CLF, Black RE. 2012. Typhoid fever and paratyphoid fever: systematic review to estimate global morbidity and mortality for 2010. J Glob Health 2: 010401. http://dx.doi.org/10.7189/jogh .02.010401.
8. Hassing RJ, Menezes GA, van Pelt W, Petit PL, van Genderen PJ, Goessens WH. 2011. Analysis of mechanisms involved in reduced susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A isolates from travellers to Southeast Asia. Int J Antimicrob Agents 37: 240 -243. http://dx.doi.org/10.1016/j.ijantimicag .2010.10.026.
9. Chen HM, Wang Y, Su LH, Chiu CH. 2013. Nontyphoid salmonella infection: microbiology, clinical features, and antimicrobial therapy. Pediatr Neonatol 54:147-152. http://dx.doi.org/10.1016/j.pedneo.2013.01.010.
10. Kim DM, Neupane GP, Jang SJ, Kim SH, Lee BK. 2010. In vitro efficacy of the combination of ciprofloxacin and cefotaxime against nalidixic acid resistant Salmonella enterica serotype Typhi. Int J Antimicrob Agents 36: 155-158. http://dx.doi.org/10.1016/j.ijantimicag.2010.03.022.
11. Olsen SJ, DeBess EE, McGivern TE, Marano N, Eby T, Mauvais S, Balan VK, Zirnstein G, Cieslak PR, Angulo FJ. 2001. A nosocomial outbreak of fluoroquinolone-resistant salmonella infection. N Engl J Med 344:1572-1579. http://dx.doi.org/10.1056/NEJM200105243442102.
12. Hsueh PR, Teng LJ, Tseng SP, Chang CF, Wan JH, Yan JJ, Lee CM, Chuang YC, Huang WK, Yang D, Shyr JM, Yu KW, Wang LS, Lu JJ, Ko WC, Wu JJ, Chang FY, Yang YC, Lau YJ, Liu YC, Liu CY, Ho SW, Luh KT. 2004. Ciprofloxacin-resistant Salmonella enterica Typhimurium and Choleraesuis from pigs to humans, Taiwan. Emerg Infect Dis 10:60-68. http://dx.doi.org/10.3201/eid1001.030171.
13. Hassing RJ, Goessens WH, van Pelt W, Mevius DJ, Stricker BH, Molhoek N, Verbon A, van Genderen PJ. 2014. Salmonella subtypes with increased MICs for azithromycin in travelers returned to the Netherlands. Emerg Infect Dis 20:705-708. http://dx.doi.org/10.3201/eid2004 .131536.
14. Abgottspon H, Zurfluh K, Nüesch-Inderbinen M, Hächler H, Stephan R. 2014. Quinolone resistance mechanisms in Salmonella enterica serovars Hadar, Kentucky, Virchow, Schwarzengrund, and 4,5,12:i:-, isolated from humans in Switzerland, and identification of a novel qnrD variant, qnrD2, in S. Hadar. Antimicrob Agents Chemother 58:3560-3563. http: //dx.doi.org/10.1128/AAC.02404-14.
15. Doublet B, Praud K, Nguyen-Ho-Bao T, Argudín MA, Bertrand S, Butaye P, Cloeckaert A. 2014. Extended-spectrum β-lactamase- and AmpC β-lactamase-producing D-tartrate-positive Salmonella enterica serovar Paratyphi B from broilers and human patients in Belgium, 2008-10. J Antimicrob Chemother 69:1257-1264. http://dx.doi.org/10.1093/jac /dkt504.
16. Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A. 2009. Plasmidmediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev 22:664-689. http://dx.doi.org/10.1128/CMR.00016-09.
17. Robicsek A, Strahilevitz J, Jacoby GA, Macielag M, Abbanat D, Park CH, Bush K, Hooper DC. 2006. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med 12:83-88. http://dx.doi.org/10.1038/nm1347.
18. Gniadkowski M. 2008. Evolution of extended-spectrum beta-lactamases by mutation. Clin Microbiol Infect 14(Suppl 1):11-32. http://dx.doi.org /10.1111/j.1469-0691.2007.01854.x.
19. Paterson DL, Bonomo RA. 2005. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 18:657-686. http://dx.doi.org/10.1128 /CMR.18.4.657-686.2005.
20. Livermore DM. 2012. Fourteen years in resistance. Int J Antimicrob Agents 39:283-294. http://dx.doi.org/10.1016/j.ijantimicag.2011.12.012.
21. Savard P, Gopinath R, Zhu W, Kitchel B, Rasheed JK, Tekle T, Roberts A, Ross T, Razeq J, Landrum BM, Wilson LE, Limbago B, Perl TM, Carroll KC. 2011. First NDM-positive Salmonella sp. strain identified in the United States. Antimicrob Agents Chemother 55:5957-5958. http://dx .doi.org/10.1128/AAC.05719-11.
22. Le Hello S, Harrois D, Bouchrif B, Sontag L, Elhani D, Guibert V, Zerouali K, Weill FX. 2013. Highly drug-resistant Salmonella enterica serotype Kentucky ST198-X1: a microbiological study. Lancet Infect Dis 13:672-679. http://dx.doi.org/10.1016/S1473-3099(13)70124-5.
23. Seiffert SN, Perreten V, Johannes S, Droz S, Bodmer T, Endimiani A. 2014. OXA-48 carbapenemase-producing Salmonella enterica serovar Kentucky isolate of sequence type 198 in a patient transferred from Libya to Switzerland. Antimicrob Agents Chemother 58:2446-2449. http://dx .doi.org/10.1128/AAC.02417-13.
24. th ed. WHO Collaborating Centre for Reference and Research on Salmonella, World Health Organization, Institut Pasteur, Paris, France.
25. European Committee on Antimicrobial Susceptibility Testing. 2014. Breakpoint tables for interpretation of MICs and zone diameters, version 4.0, 2014. http://www.eucast.org/fileadmin/src/media/PDFs /EUCAST-files/Breakpoint-tables/Breakpoint-table-v-4.0.pdf.
26. Clinical and Laboratory Standards Institute. 2014. Performance standards for antimicrobial susceptibility testing; twenty-fourth informa-tional supplement. CLSI M100-S24. Clinical and Laboratory Standards Institute, Wayne, PA.
27. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. 2012. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18: 268-281. http://dx.doi.org/10.1111/j.1469-0691.2011.03570.x.
28. Chiu CH, Wu TL, Su LH, Chu C, Chia JH, Kuo AJ, Chien MS, Lin TY. 2002. The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype choleraesuis. N Engl J Med 346:413-419. http://dx .doi.org/10.1056/NEJMoa012261.
29. Yue L, Jiang HX, Liao XP, Liu JH, Li SJ, Chen XY, Chen CX, Lü DH, Liu YH. 2008. Prevalence of plasmid-mediated quinolone resistance qnr genes in poultry and swine clinical isolates of Escherichia coli. Vet Microbiol 132:414-420. http://dx.doi.org/10.1016/j.vetmic.2008.05.009.
30. Cavaco LM, Frimodt-Møller N, Hasman H, Guardabassi L, Nielsen L, Aarestrup FM. 2008. Prevalence of quinolone resistance mechanisms and associations to minimum inhibitory concentrations in quinolone-resistant E. coli isolated from humans and swine in Denmark. Microb Drug Resist 14: 163-169. http://dx.doi.org/10.1089/mdr .2008.0821.
31. Cattoir V, Poirel L, Rotimi V, Soussy CJ, Nordmann P. 2007. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother 60: 394-397. http://dx.doi.org/10.1093/jac/dkm204.
32. Olesen I, Hasman H, Aarestrup FM. 2004. Prevalence of beta-lactamases among ampicillin-resistant Escherichia coli and Salmonella isolated from food animals in Denmark. Microb Drug Resist 10:334-340. http://dx.doi .org/10.1089/mdr.2004.10.334.
33. Hasman H, Mevius D, Veldman K, Olesen I, Aarestrup FM. 2005. Beta-lactamases among extended spectrum beta-lactamase resistant (ESBL) Salmonella from poultry, poultry products and human patients in The Netherlands. J Antimicrob Chemother 56:115-121. http://dx.doi.org /10.1093/jac/dki190.
34. Wuyts V, Mattheus W, De Laminne de Bex G, Wildemauwe C, Roosens NH, Marchal K, De Keersmaecker SC, Bertrand S. 2013. MLVA as a tool for public health surveillance of human Salmonella Typhimurium: prospective study in Belgium and evaluation ofMLVAloci stability. PLoS One 8:e84055. http://dx.doi.org/10.1371/journal.pone.0084055.
35. Lindstedt BA, Vardund T, Aas L, Kapperud G. 2004. Multiple-locus variable-number tandem-repeats analysis of Salmonella enterica subsp. enterica serovar Typhimurium using PCR multiplexing and multicolor capillary electrophoresis. J Microbiol Methods 59:163-172. http://dx.doi .org/10.1016/j.mimet.2004.06.014.
36. Larsson JT, Torpdahl M, Petersen RF, Sorensen G, Lindstedt BA, Nielsen EM. 2009. Development of a new nomenclature for Salmonella Typhimurium multilocus variable number of tandem repeats analysis (MLVA). Euro Surveill 14(15):pii=19174. http://www.eurosurveillance .org/ViewArticle.aspx?ArticleId=19174.
37. Hunter SB, Vauterin P, Lambert-Fair MA, Van Duyne MS, Kubota K, Graves L, Wrigley D, Barrett T, Ribot E. 2005. Establishment of a universal size standard strain for use with the PulseNet standardized pulsed field gel electrophoresis protocols: converting the national databases to the new size standard. J Clin Microbiol 43:1045-1050. http://dx .doi.org/10.1128/JCM.43.3.1045-1050.2005.
38. Rabsch W, Andrews HL, Kingsley RA, Prager R, Tschäpe H, Adams LG, Bäumler AJ. 2002. Salmonella enterica serotype Typhimurium and its host-adapted variants. Infect Immun 70:2249-2255. http://dx.doi.org/10 .1128/IAI.70.5.2249-2255.2002.
39. Baudart J, Lemarchand K, Brisabois A, Lebaron P. 2000. Diversity of Salmonella strains isolated from the aquatic environment as determined by serotyping and amplification of the ribosomal DNA spacer regions. Appl Environ Microbiol 66:1544-1552. http://dx.doi.org/10.1128/AEM .66.4.1544-1552.2000.
40. Collard JM, Bertrand S, Dierick K, Godard C, Wildemauwe C, Vermeersch K, Duculot J, Van Immerseel F, Pasmans F, Imberechts H, Quinet C. 2008. Drastic decrease of Salmonella Enteritidis isolated from humans in Belgium in 2005, shift in phage types and influence on foodborne outbreaks. Epidemiol Infect 136:771-781. http://dx.doi.org/10 .1017/S095026880700920X.
41. Kinross P, van Alphen L, Martinez Urtaza J, Struelens M, Takkinen J, Coulombier D, Mäkelä P, Bertrand S, Mattheus W, Schmid D, Kanitz E, Rücker V, Krisztalovics K, Pászti J, Szögyényi Z, Lancz Z, Rabsch W, Pfefferkorn B, Hiller P, Mooijman K, Gossner C. 2014. Multidisciplinary investigation of a multicountry outbreak of Salmonella Stanley infections associated with turkey meat in the European Union, August 2011 to January 2013. Euro Surveill 19(19):pii=20801. http://www .eurosurveillance.org/ViewArticle.aspx?ArticleId=20801.
42. Johnson LR, Gould LH, Dunn JR, Berkelman R, Mahon BE, FoodNet Travel Working Group. 2011. Salmonella infections associated with international travel: a Foodborne Diseases Active Surveillance Network (Food-Net) study. Foodborne Pathog Dis 8: 1031-1037. http://dx.doi.org/10 .1089/fpd.2011.0854.
43. Centers for Disease Control and Prevention. 2011. Vital signs: incidence and trends of infection with pathogens transmitted commonly through food-Foodborne Diseases Active Surveillance Network, 10 U.S. sites, 1996-2010. MMWR Morb Mortal Wkly Rep 60:749-755.
44. Boyd D, Cloeckaert A, Chaslus-Dancla E, Mulvey MR. 2002. Characterization of variant Salmonella genomic island 1 multidrug resistance regions from serovars Typhimurium DT104 and Agona. Antimicrob Agents Chemother 46:1714-1722. http://dx.doi.org/10.1128/AAC.46.6.1714-1722.2002.
45. Westrell T, Monnet DL, Gossner C, Heuer O, Takkinen J. 2014. Drugresistant Salmonella enterica serotype Kentucky in Europe. Lancet Infect Dis 14:270-271. http://dx.doi.org/10.1016/S1473-3099(14)70703-0.
46. Hopkins KL, Davies RH, Threlfall EJ. 2005. Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments. Int J Antimicrob Agents 25:358-373. http://dx.doi.org/10.1016/j.ijantimicag .2005.02.006.
47. Jeong HS, Kim JA, Shin JH, Chang CL, Jeong J, Cho JH, Kim MN, Kim S, Kim YR, Lee CH, Lee K, Lee MA, Lee WG, Shin JH, Lee JN. 2011. Prevalence of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes in Salmonella isolated from 12 tertiary-care hospitals in Korea. Microb Drug Resist 17:551-557. http://dx .doi.org/10.1089/mdr.2011.0095.
48. Walther-Rasmussen J, Høiby N. 2011. Salmonella enterica serovar Typhi and S. Paratyphi A: need to expand the QRDR region? Epidemiol Infect 139:1281-1283. http://dx.doi.org/10.1017/S0950268810002487.
49. Wasyl D, Hoszowski A, Zając M. 2014. Prevalence and characterisation of quinolone resistance mechanisms in Salmonella spp. Vet Microbiol 171:307-314. http://dx.doi.org/10.1016/j.vetmic.2014.01.040.
50. Towne TG, Lewis JS, Jr, Herrera M, Wickes B, Jorgensen JH. 2010. Detection of SHV-type extended-spectrum beta-lactamase in Enterobacter isolates. J Clin Microbiol 48:298-299. http://dx.doi.org/10.1128/ JCM.01875-09.
51. Jacoby GA. 2009. AmpC beta-lactamases. Clin Microbiol Rev 22:161-182. http://dx.doi.org/10.1128/CMR.00036-08.
52. Whichard JM, Gay K, Stevenson JE, Joyce KJ, Cooper KL, Omondi M, Medalla F, Jacoby GA, Barrett TJ. 2007. Human Salmonella and concurrent decreased susceptibility to quinolones and extended-spectrum cephalosporins. Emerg Infect Dis 13:1681-1688. http://dx.doi.org/10.3201/eid131 1.061438.
53. Burke L, Hopkins KL, Meunier D, de Pinna E, Fitzgerald-Hughes D, Humphreys H, Woodford N. 2014. Resistance to third-generation cephalosporins in human non-typhoidal Salmonella enterica isolates from England and Wales, 2010-12. J Antimicrob Chemother 69:977-981. http: //dx.doi.org/10.1093/jac/dkt469.
54. Menezes GA, Khan MA, Harish BN, Parija SC, Goessens W, Vidyalakshmi K, Baliga S, Hays JP. 2010. Molecular characterization of antimicrobial resistance in non-typhoidal salmonellae associated with systemic manifestations from India. J Med Microbiol 59:1477-1478. http://dx.doi .org/10.1099/jmm.0.022319-0.
55. Boyle F, Healy G, Hale J, Kariuki S, Cormican M, Morris D. 2011. Characterization of a novel extended-spectrum β-lactamase phenotype from OXA-1 expression in Salmonella Typhimurium strains from Africa and Ireland. Diagn Microbiol Infect Dis 70:549-553. http://dx.doi.org/10 .1016/j.diagmicrobio.2011.04.007.
56. Cloeckaert A, Praud K, Doublet B, Bertini A, Carattoli A, Butaye P, Imberechts H, Bertrand S, Collard JM, Arlet G, Weill FX. 2007. Dissemination of an extended-spectrum-beta-lactamase bla TEM- 52 genecarrying IncI1 plasmid in various Salmonella enterica serovars isolated from poultry and humans in Belgium and France between 2001 and 2005. Antimicrob Agents Chemother 51:1872-1875. http://dx.doi.org/10.1128 /AAC.01514-06.
57. Liebana E, Carattoli A, Coque TM, Hasman H, Magiorakos AP, Mevius D, Peixe L, Poirel L, Schuepbach-Regula G, Torneke K, Torren-Edo J, Torres C, Threlfall J. 2013. Public health risks of enterobacterial isolates producing extended-spectrum β-lactamases or AmpC β-lactamases in food and food-producing animals: an EU perspective of epidemiology, analytical methods, risk factors, and control options. Clin Infect Dis 56: 1030-1037. http://dx.doi.org/10.1093/cid/cis1043.
58. de Jong A, Smet A, Ludwig C, Stephan B, De Graef E, Vanrobaeys M, Haesebrouck F. 2014. Antimicrobial susceptibility of Salmonella isolates from healthy pigs and chickens (2008 -2011). Vet Microbiol 171:298-306. http://dx.doi.org/10.1016/j.vetmic.2014.01.030.
59. Herrera-León S, González-Sanz R, Herrera-León L, Echeita MA. 2011. Characterization of multidrug-resistant Enterobacteriaceae carrying plas-mid-mediated quinolone resistance mechanisms in Spain. J Antimicrob Chemother 66:287-290. http://dx.doi.org/10.1093/jac/dkq423.